MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 9, 2015, Pages 2084-2097

  Wang, Hongjiang ^a   Li, Jing ^a   Chi, Hongjie ^a   Zhang, Fan ^a   Zhu, Xiaoming ^a   Cai, Jun ^a   Yang, Xinchun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bcl 2; MicroRNA; Mitochondria

Indexed keywords

CASPASE 3; CYTOCHROME C; MICRORNA; MICRORNA 181C; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; MIRN181 MICRORNA, MOUSE; MITOCHONDRIAL DNA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL SELECTION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENE SEQUENCE; GENETIC TRANSFECTION; HEART MUSCLE CELL; LUCIFERASE ASSAY; MITOCHONDRION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; 3' UNTRANSLATED REGION; 3T3 CELL LINE; ANIMAL; CARDIAC MUSCLE; CELL SURVIVAL; CONSERVED SEQUENCE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEART MITOCHONDRION; METABOLISM; MITOCHONDRIAL MEMBRANE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REPORTER GENE; SIGNAL TRANSDUCTION; ULTRASTRUCTURE;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CELL SURVIVAL; CONSERVED SEQUENCE; DNA, MITOCHONDRIAL; GENE EXPRESSION REGULATION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; MICE; MICRORNAS; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANES; MOLECULAR SEQUENCE DATA; MYOCARDIUM; NIH 3T3 CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84940788564     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12563     Document Type: Article

References (60)

1. Chen JQ, Cammarata PR, Baines CP, et al. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta. 2009; 1793: 1540-70.
2. Murphy E, Steenbergen C. What makes the mitochondria a killer? Can we condition them to be less destructive? Biochim Biophys Acta. 2011; 1813: 1302-8.
3. Rolland SG, Conradt B. New role of the BCL2 family of proteins in the regulation of mitochondrial dynamics. Curr Opin Cell Biol. 2010; 22: 852-8.
4. Danial NN, Gimenez-Cassina A, Tondera D. Homeostatic functions of BCL-2 proteins beyond apoptosis. Adv Exp Med Biol. 2010; 687: 1-32.
5. Tang Y, Zheng J, Sun Y, et al. MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J. 2009; 50: 377-87.
6. Chen Z, Chua CC, Ho YS, et al. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol. 2001; 280: H2313-20.
7. Imahashi K, Schneider MD, Steenbergen C, et al. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ Res. 2004; 95: 734-41.
8. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008; 9: 102-14.
9. Behm-Ansmant I, Rehwinkel J, Izaurralde E. MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb Symp Quant Biol. 2006; 71: 523-30.
10. Sun H, Wang Y. Restriction of big hearts by a small RNA. Circ Res. 2011; 108: 274-6.
11. van Rooij E, Marshall WS, Olson EN. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ Res. 2008; 103: 919-28.
12. Kukreja RC, Yin C, Salloum FN. MicroRNAs: new players in cardiac injury and protection. Mol Pharmacol. 2011; 80: 558-64.
13. Yin C, Salloum FN, Kukreja RC. A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circ Res. 2009; 104: 572-5.
14. Yin C, Wang X, Kukreja RC. Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice. FEBS Lett. 2008; 582: 4137-42.
15. Androulidaki A, Iliopoulos D, Arranz A, et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity. 2009; 31: 220-31.
16. Bandiera S, Ruberg S, Girard M, et al. Nuclear outsourcing of RNA interference components to human mitochondria. PLoS ONE. 2011; 6: e20746.
17. Barrey E, Saint-Auret G, Bonnamy B, et al. Pre-microRNA and mature microRNA in human mitochondria. PLoS ONE. 2011; 6: e20220.
18. Bian Z, Li LM, Tang R, et al. Identification of mouse liver mitochondria-associated miRNAs and their potential biological functions. Cell Res. 2010; 20: 1076-8.
19. Kren BT, Wong PY, Sarver A, et al. MicroRNAs identified in highly purified liver-derived mitochondria may play a role in apoptosis. RNA Biol. 2009; 6: 65-72.
20. Liu T, Tang H, Lang Y, et al. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett. 2009; 273: 233-42.
21. Brand NJ, Lara-Pezzi E, Rosenthal N, et al. Analysis of cardiac myocyte biology in transgenic mice: a protocol for preparation of neonatal mouse cardiac myocyte cultures. Methods Mol Biol. 2010; 633: 113-24.
22. Hornig-Do HT, Gunther G, Bust M, et al. Isolation of functional pure mitochondria by superparamagnetic microbeads. Anal Biochem. 2009; 389: 1-5.
23. Han RQ, Ouyang YB, Xu L, et al. Postischemic brain injury is attenuated in mice lacking the beta2-adrenergic receptor. Anesth Analg. 2009; 108: 280-7.
24. Ouyang YB, Carriedo SG, Giffard RG. Effect of Bcl-x(L) overexpression on reactive oxygen species, intracellular calcium, and mitochondrial membrane potential following injury in astrocytes. Free Radic Biol Med. 2002; 33: 544-51.
25. Guerra S, Leri A, Wang X, et al. Myocyte death in the failing human heart is gender dependent. Circ Res. 1999; 85: 856-66.
26. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med. 1997; 336: 1131-41.
27. Saraste A, Pulkki K, Kallajoki M, et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest. 1999; 29: 380-6.
28. Vaux DL. A boom time for necrobiology. Curr Biol. 1993; 3: 877-8.
29. Wang K, Yin XM, Chao DT, et al. BID: a novel BH3 domain-only death agonist. Genes Dev. 1996; 10: 2859-69.
30. Hoppins S, Edlich F, Cleland MM, et al. The soluble form of Bax regulates mitochondrial fusion via MFN2 homotypic complexes. Mol Cell. 2011; 41: 150-60.
31. Lee YJ, Jeong SY, Karbowski M, et al. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell. 2004; 15: 5001-11.
32. Olichon A, Baricault L, Gas N, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem. 2003; 278: 7743-6.
33. Mancini M, Anderson BO, Caldwell E, et al. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J Cell Biol. 1997; 138: 449-69.
34. De Vos K, Goossens V, Boone E, et al. The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region. J Biol Chem. 1998; 273: 9673-80.
35. Karbowski M, Lee YJ, Gaume B, et al. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol. 2002; 159: 931-8.
36. Neupert W, Herrmann JM. Translocation of proteins into mitochondria. Annu Rev Biochem. 2007; 76: 723-49.
37. Soriano ME, Scorrano L. Traveling Bax and forth from mitochondria to control apoptosis. Cell. 2011; 145: 15-7.
38. Fesik SW, Shi Y. Structural biology. Controlling the caspases. Science. 2001; 294: 1477-8.
39. Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 2003; 22: 8590-607.
40. Hsu YT, Wolter KG, Youle RJ. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci USA. 1997; 94: 3668-72.
41. Moulton V. Tracking down noncoding RNAs. Proc Natl Acad Sci USA. 2005; 102: 2269-70.
42. Tuschl T. Functional genomics: RNA sets the standard. Nature. 2003; 421: 220-1.
43. Chen WX, Hu Q, Qiu MT, et al. miR-221/222: promising biomarkers for breast cancer. Tumour Biol. 2013; 34: 1361-70.
44. Creevey L, Ryan J, Harvey H, et al. MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1. Mol Cancer. 2013; 12: 23.
45. Zhang J, Liu Y, Liu Z, et al. Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma. Int J Med Sci. 2013; 10: 585-92.
46. Chen JD, Zhu H, Zhang Y. [Latest advances of studies on microRNA regulation in dendritic cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013; 21: 222-6.
47. Fu G, Brkic J, Hayder H, et al. MicroRNAs in human placental development and pregnancy complications. Int J Mol Sci. 2013; 14: 5519-44.
48. Ambros V. The functions of animal microRNAs. Nature. 2004; 431: 350-5.
49. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-97.
50. Cordes KR, Srivastava D. MicroRNA regulation of cardiovascular development. Circ Res. 2009; 104: 724-32.
51. Sheth U, Parker R. Targeting of aberrant mRNAs to cytoplasmic processing bodies. Cell. 2006; 125: 1095-109.
52. Wu L, Belasco JG. Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell. 2008; 29: 1-7.
53. Bhattacharyya SN, Habermacher R, Martine U, et al. Stress-induced reversal of microRNA repression and mRNA P-body localization in human cells. Cold Spring Harb Symp Quant Biol. 2006; 71: 513-21.
54. Zhu X, Wang H, Liu F, et al. Identification of micro-RNA networks in end-stage heart failure because of dilated cardiomyopathy. J Cell Mol Med. 2013; 17: 1173-87.
55. Chen CZ, Li L, Lodish HF, et al. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004; 303: 83-6.
56. Li QJ, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007; 129: 147-61.
57. Zimmerman EI, Dollins CM, Crawford M, et al. Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia. Mol Pharmacol. 2010; 78: 811-7.
58. Garland JM, Halestrap A. Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest. J Biol Chem. 1997; 272: 4680-8.
59. Manfredi G, Kwong JQ, Oca-Cossio JA, et al. BCL-2 improves oxidative phosphorylation and modulates adenine nucleotide translocation in mitochondria of cells harboring mutant mtDNA. J Biol Chem. 2003; 278: 5639-45.
60. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004; 116: 205-19.